-
June 15, 2021 University of Calgary Creates Canada’s First Chair for Psychedelic ResearchCanada gets its first chair for psychedelic research thanks to private citizen funding to the...
-
June 14, 2021 80 to 100% of Amputees Experience Phantom Limb Syndrome. Psilocybin May Help.New research into psychedelics shows psilocybin may help amputees suffering from pain associated with phantom...
-
June 11, 2021 Psychedelic Business Spotlight: June 11, 2021This week in psychedelic business news: An all-female biotech company, psychedelic-assisted psychotherapy for COVID front-liners,...
-
June 10, 2021 First-of-Its-Kind Genetic Psychedelic Test Kit Now Available In U.S.The first genetic psychedelic test kit is now available in the U.S. The kits are...
-
June 10, 2021 Seattle Council Tasks Drug Overdose Panel With Exploring Decriminalizing PsychedelicsSeattle city council members are being asked to review decriminalizing psychedelics.
-
June 10, 2021 Psilocybin Shows Promise As Treatment for MigrainesA new investigation into treatment for migraines spotlights the psychedelic psilocybin mushroom as a promising...
-
June 9, 2021 Connecticut Governor Signs Psychedelic Reform DealConnecticut has become the newest state to consider reform proposals regarding psychedelic medicines.
-
June 8, 2021 Cybin Launches First Clinical Trial to Treat Frontline Workers Experiencing COVID-Related Distress With PsychedelicsA new first-of-its-kind psychedelic study will treat frontline workers experiencing distress related to COVID with...
-
June 8, 2021 Field Trip Health Begins Trading on TSE, Sets Sights on NasdaqPsychedelic lifestyle brand Field Trip Health is now trading on the Toronto Stock Exchange under...
-
June 7, 2021 GH Research Is Taking Psychedelic 5-MeO-DMT ‘Toad Venom’ PublicGH Research is taking its psychedelic 5-MeO-DMT public on the Nasdaq with an IPO valued...
